HKD 0.89
(-1.11%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 979.44 Million CNY | 26.24% |
2022 | 775.84 Million CNY | 40.05% |
2021 | 553.98 Million CNY | 3.97% |
2020 | 532.81 Million CNY | 27.14% |
2019 | 419.09 Million CNY | 2.65% |
2018 | 408.26 Million CNY | 43.88% |
2017 | 283.75 Million CNY | 176.13% |
2016 | 102.76 Million CNY | 2.24% |
2015 | 100.51 Million CNY | -28.04% |
2014 | 139.68 Million CNY | 23.18% |
2013 | 113.39 Million CNY | -2.58% |
2012 | 116.4 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 972.73 Million CNY | 0.0% |
2023 Q4 | 979.44 Million CNY | 0.0% |
2023 Q2 | 781.71 Million CNY | 0.0% |
2023 FY | 979.44 Million CNY | 26.24% |
2022 Q4 | 775.84 Million CNY | 0.0% |
2022 FY | 775.84 Million CNY | 40.05% |
2022 Q2 | 679.26 Million CNY | 0.0% |
2021 Q2 | 563.55 Million CNY | 0.0% |
2021 FY | 553.98 Million CNY | 3.97% |
2021 Q4 | 553.98 Million CNY | 0.0% |
2020 FY | 532.81 Million CNY | 27.14% |
2020 Q2 | 439.68 Million CNY | 0.0% |
2020 Q4 | 532.81 Million CNY | 0.0% |
2019 FY | 419.09 Million CNY | 2.65% |
2019 Q4 | 419.09 Million CNY | 0.0% |
2019 Q2 | 430.74 Million CNY | 0.0% |
2018 Q4 | 408.26 Million CNY | 0.0% |
2018 FY | 408.26 Million CNY | 43.88% |
2018 Q2 | 403.15 Million CNY | 0.0% |
2017 Q2 | 136.88 Million CNY | 0.0% |
2017 Q4 | 283.75 Million CNY | 0.0% |
2017 FY | 283.75 Million CNY | 176.13% |
2016 Q4 | 102.76 Million CNY | 0.0% |
2016 Q2 | 96.38 Million CNY | 0.0% |
2016 FY | 102.76 Million CNY | 2.24% |
2015 Q2 | 125.7 Million CNY | 0.0% |
2015 FY | 100.51 Million CNY | -28.04% |
2015 Q4 | 100.51 Million CNY | 0.0% |
2014 Q2 | 108.92 Million CNY | 0.0% |
2014 FY | 139.68 Million CNY | 23.18% |
2014 Q4 | 139.68 Million CNY | 0.0% |
2013 Q2 | - CNY | 0.0% |
2013 FY | 113.39 Million CNY | -2.58% |
2013 Q4 | 113.39 Million CNY | 0.0% |
2012 FY | 116.4 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -217.941% |
Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 7.912% |
China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -797.742% |
Prosperous Future Holdings Limited | 177.1 Million HKD | -453.018% |
Huasheng International Holding Limited | 675.58 Million HKD | -44.978% |
Fourace Industries Group Holdings Limited | 61.8 Million HKD | -1484.734% |
Evergreen Products Group Limited | 786.46 Million HKD | -24.537% |
EC Healthcare | 2.97 Billion HKD | 67.025% |
Ming Fai International Holdings Limited | 772.01 Million HKD | -26.869% |
Blue Moon Group Holdings Limited | 1.61 Billion HKD | 39.459% |
SuperRobotics Holdings Limited | 172.27 Million HKD | -468.546% |
Takbo Group Holdings Limited | 42.84 Million HKD | -2185.806% |
Hyfusin Group Holdings Limited | 181.34 Million HKD | -440.091% |